These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19758575)

  • 1. Adjunctive quetiapine may help depression comorbid with pervasive developmental disorders.
    Tufan AE; Kutlu H
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1570-1. PubMed ID: 19758575
    [No Abstract]   [Full Text] [Related]  

  • 2. Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders.
    Hardan AY; Jou RJ; Handen BL
    J Autism Dev Disord; 2005 Jun; 35(3):387-91. PubMed ID: 16119479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine: another drug with potential for misuse? A case report.
    Paparrigopoulos T; Karaiskos D; Liappas J
    J Clin Psychiatry; 2008 Jan; 69(1):162-3. PubMed ID: 18312052
    [No Abstract]   [Full Text] [Related]  

  • 4. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risperidone in pervasive developmental disorders.
    Erickson CA; Stigler KA; Posey DJ; McDougle CJ
    Expert Rev Neurother; 2005 Nov; 5(6):713-9. PubMed ID: 16274329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine.
    Himmerich H; Ehrlinger M; Hackenberg M; Löhr B; Nickel T
    J Clin Psychopharmacol; 2006 Dec; 26(6):676-7. PubMed ID: 17110835
    [No Abstract]   [Full Text] [Related]  

  • 7. Risperidone in PDD.
    Fisman S; Steele M; Pipher B
    J Am Acad Child Adolesc Psychiatry; 1998 Jan; 37(1):15-6. PubMed ID: 9444894
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacotherapy of irritability in pervasive developmental disorders.
    Stigler KA; McDougle CJ
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence of improvement of depressive symptoms but not impulsivity in cluster B personality disorder patients treated with quetiapine: an open label trial.
    Roepke S; Merkl A; Dams A; Ziegenhorn A; Anghelescu IG; Heuser I; Lammers CH
    Pharmacopsychiatry; 2008 Sep; 41(5):176-81. PubMed ID: 18763219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine in the treatment of rapid-cycling bipolar II disorder with comorbid anxiety and social phobia -- a case report.
    Valerius G; Biedermann NC; Schaerer LO; Langosch JM
    Pharmacopsychiatry; 2005 Sep; 38(5):225-6. PubMed ID: 16189752
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term treatment of adjunctive quetiapine for bipolar mania.
    Pae CU; Kim TS; Kim JJ; Lee SJ; Lee CU; Lee C; Paik IH
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):763-6. PubMed ID: 15951090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine in anorexia nervosa patients: an open label outpatient pilot study.
    Powers PS; Bannon Y; Eubanks R; McCormick T
    Int J Eat Disord; 2007 Jan; 40(1):21-6. PubMed ID: 16927383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very low dose quetiapine-induced galactorrhea in combination with venlafaxine.
    Pae CU; Kim JJ; Lee CU; Chae JH; Lee SJ; Lee C; Paik IH
    Hum Psychopharmacol; 2004 Aug; 19(6):433-4. PubMed ID: 15303249
    [No Abstract]   [Full Text] [Related]  

  • 17. Quetiapine for refractory schizophrenia.
    Szigethy E; Brent S; Findling RL
    J Am Acad Child Adolesc Psychiatry; 1998 Nov; 37(11):1127-8. PubMed ID: 9808917
    [No Abstract]   [Full Text] [Related]  

  • 18. Quetiapine as adjunctive treatment of a case of rapid-cycling bipolar disorder with comorbidity.
    Stratta P; de Cataldo S; Mancini G; Gianfelice D; Rinaldi O; Rossi A
    Hum Psychopharmacol; 2003 Oct; 18(7):559-60. PubMed ID: 14533138
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol decanoate in children.
    Alessi N; Alkhouri I; Fluent T; Quinlan P; Williams K
    J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):865-6. PubMed ID: 11501680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.